Want to see HK:2159 full AI Analyst Report?
Top Page
Mediwelcome Healthcare Management & Technology Inc.
(2159)
Select Model
Select Model
Rating:54Neutral
Price Target:
HK$2.00
▲(61.29% Upside)
Action:Reiterated
Date:08/06/26
Overall score is held back primarily by uneven financial quality: despite strong 2025 revenue growth and a return to net profitability, operating margins are very thin and cash-flow consistency remains weak. Technicals are supportive with price above key moving averages and a positive MACD, but overbought signals (RSI ~70) add near-term risk. Valuation is a notable headwind given the high P/E and no dividend yield provided.
Positive Factors
Strong revenue growth and return to profitability
Sustained 48% top-line growth and a return to net profit indicate durable demand and improving unit economics. Over a 2–6 month horizon this revenue scale can support margin improvement initiatives, absorb fixed costs, and fund product or sales investments that reinforce competitive position.
Negative Factors
Very thin operating profitability
An operating margin near zero leaves little buffer for cost increases or weaker revenue, making profitability vulnerable to normal business volatility. Sustaining long-term growth while converting revenue into durable operating earnings will require meaningful margin expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth and return to profitability
Sustained 48% top-line growth and a return to net profit indicate durable demand and improving unit economics. Over a 2–6 month horizon this revenue scale can support margin improvement initiatives, absorb fixed costs, and fund product or sales investments that reinforce competitive position.
Read all positive factors
Mediwelcome Healthcare Management & Technology Inc. (2159) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$578.75M
Dividend YieldN/A
Average Volume (3M)143.16K
Price to Earnings (P/E)10.5
Beta (1Y)0.55
Revenue Growth91.32%
EPS GrowthN/A
CountryHK
Employees150
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)0.14
Shares Outstanding336,480,000
10 Day Avg. Volume189,680
30 Day Avg. Volume143,160
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)2.15
Price to Sales (P/S)0.51
P/FCF Ratio96.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mediwelcome Healthcare Management & Technology Inc. Business Overview & Revenue Model
Company Description
As an investment holding entity, Mediwelcome Healthcare Management & Technology Inc. delivers comprehensive marketing solutions for the healthcare sector within the People's Republic of China. Its service portfolio encompasses medical conference o...
How the Company Makes Money
null...
Mediwelcome Healthcare Management & Technology Inc. Financial Statement Overview
Summary
Income Statement
54
Neutral
Balance Sheet
63
Positive
Cash Flow
42
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 568.69M | 468.02M | 321.56M | 331.31M | 323.37M | 708.36M |
| Gross Profit | 141.70M | 94.71M | 51.00M | 29.89M | 32.55M | 93.60M |
| EBITDA | 27.62M | 2.81M | -33.61M | -74.53M | -69.08M | 11.32M |
| Net Income | 33.77M | 9.99M | -45.24M | -94.10M | -89.20M | 4.64M |
Balance Sheet | ||||||
| Total Assets | 447.83M | 190.57M | 194.09M | 214.32M | 317.83M | 366.70M |
| Cash, Cash Equivalents and Short-Term Investments | 138.52M | 99.36M | 71.66M | 80.35M | 154.02M | 174.83M |
| Total Debt | 65.10M | 54.49M | 47.73M | 31.13M | 26.48M | 25.18M |
| Total Liabilities | 267.64M | 85.14M | 120.81M | 94.35M | 116.97M | 73.21M |
| Stockholders Equity | 129.85M | 111.30M | 71.14M | 116.13M | 195.02M | 283.11M |
Cash Flow | ||||||
| Free Cash Flow | 3.73M | 2.47M | -27.10M | -77.18M | -22.75M | -24.73M |
| Operating Cash Flow | 4.03M | 2.88M | -14.05M | -75.58M | -18.46M | 262.00K |
| Investing Cash Flow | -6.36M | -13.28M | -326.00K | 16.46M | -8.36M | -16.77M |
| Financing Cash Flow | 46.43M | 37.34M | 5.68M | 906.00K | 54.00K | 92.84M |
Mediwelcome Healthcare Management & Technology Inc. Technical Analysis
Positive
1.24
Price Trends
1.67
Positive
1.63
Positive
1.51
Positive
Market Momentum
<0.01
Positive
50.11
Neutral
27.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2159, the sentiment is Positive. The current price of 1.24 is below the 20-day moving average (MA) of 1.74, below the 50-day MA of 1.67, and below the 200-day MA of 1.51, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 50.11 is Neutral, neither overbought nor oversold. The STOCH value of 27.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2159.
Mediwelcome Healthcare Management & Technology Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$1.65B | 9.21 | 43.78% | 11.10% | -14.68% | -13.60% | |
56 Neutral | HK$1.22B | 85.71 | 0.48% | 1.00% | -3.26% | ― | |
54 Neutral | HK$578.75M | 10.50 | 28.00% | ― | 91.32% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | HK$936.00M | 23.51 | 5.59% | ― | ― | ― | |
48 Neutral | HK$4.23B | 51.57 | 1.88% | 1.01% | 16.87% | ― | |
46 Neutral | HK$515.57M | -1.28 | -25.36% | 1.47% | -8.94% | -140.82% |
* Healthcare Sector Average
HK:2159
Mediwelcome Healthcare Management & Technology Inc.
1.72
0.23
15.44%
HK:9906
Honliv Healthcare Management Group Co Ltd
1.56
0.06
4.00%
HK:1830
Perfect Medical Health Management Limited
1.31
-0.10
-7.22%
HK:2138
EC Healthcare
0.44
-0.39
-47.59%
HK:2158
Yidu Tech, Inc.
3.97
-2.16
-35.27%
HK:3886
Town Health International Medical Group Ltd.
0.18
-0.07
-28.57%
Mediwelcome Healthcare Management & Technology Inc. Corporate Events
Mediwelcome Turns Profitable as AI Healthcare Platforms Power Revenue Surge
Jul 31, 2026
Mediwelcome Healthcare Management Technology Inc. reported a sharp improvement in interim performance for the six months ended 30 June 2026, driven by rapid expansion of its AI digital intelligence platforms. Revenue surged 81.7% year on year to ...
Mediwelcome Extends Share Placing Deadlines Amid Compliance Checks
Jul 31, 2026
Mediwelcome Healthcare Management Technology Inc. has extended both the placing period and the long stop date for its planned issuance of new shares under a specific mandate. The company and its placing agent agreed to move these deadlines to 31 ...
Mediwelcome Signals Profit Rebound on Surging AI-Driven Revenue
Jul 28, 2026
Mediwelcome Healthcare Management Technology Inc. expects to swing to a net profit of at least RMB17 million for the six months ended 30 June 2026, from a loss of about RMB4.1 million a year earlier. The board attributes this turnaround to revenu...
Mediwelcome Sets Board Meeting to Approve Interim Results and Consider Dividend
Jul 21, 2026
Mediwelcome Healthcare Management Technology Inc. has scheduled a board meeting for July 31, 2026 to review and approve its interim results for the six months ended June 30, 2026 and to authorize their publication. The board will also consider th...
Mediwelcome Shareholders Approve All AGM Resolutions, Refresh Capital Mandates
Jun 30, 2026
Mediwelcome Healthcare Management Technology Inc. announced that shareholders unanimously approved all resolutions at the annual general meeting held on 30 June 2026. The meeting endorsed the 2025 audited financial statements, re-elected one exec...
Mediwelcome completes Mediai Technology acquisition and extends share placing timeline
Jun 26, 2026
Mediwelcome Healthcare Management Technology Inc. has completed the acquisition of 100% of Mediai Technology Development Limited, making the target an indirect wholly owned subsidiary and consolidating its financial results, assets and liabilitie...
Mediwelcome Sets 2026 AGM to Review 2025 Results and Seek Fresh Share Issuance Mandate
Jun 5, 2026
Mediwelcome Healthcare Management Technology Inc. has called its annual general meeting for 30 June 2026 in Shenzhen, where shareholders will review the audited consolidated financial statements and the reports of directors and the auditor for th...
Mediwelcome Shareholders Unanimously Back Acquisition and Placing Plans
May 28, 2026
Mediwelcome Healthcare Management Technology Inc. reported that all resolutions proposed at its extraordinary general meeting on 28 May 2026 were approved by shareholders by way of poll. Investors backed both the acquisition agreement and a placi...
Mediwelcome Calls EGM to Approve AI Acquisition and HK$1.50 Share Placing
May 8, 2026
Mediwelcome Healthcare Management Technology Inc. has called an extraordinary general meeting for 28 May 2026 in Shenzhen, where shareholders will vote on key corporate actions. The agenda reflects the company’s push to deepen its presence ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.